## Abstract Survival from breast cancer in the UK is lower than in other countries in Western Europe, the USA and Australia. However, these international differences have not yet been examined in relation to tumor characteristics, treatment, screening history or other prognostic factors. We calcula
Null association between pregnancy termination and breast cancer in a registry-based study of parous women
✍ Scribed by Timothy L. Lash; Aliza K. Fink
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 86 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Studies suggesting a positive association between pregnancy termination and breast cancer risk have often been of retrospective case‐control design, so subject to selection and recall biases. We undertook a registry‐based analysis with minimal selection bias and prospective record‐based ascertainment of terminations. The source population comprised Massachusetts women with a record of giving birth between 1987 and 1999 in the Massachusetts Vital Statistics Registry. Primary breast cancer cases were 25–55 years old at diagnosis between 1988 and 2000 and had a record of the diagnosis in the Massachusetts Cancer Registry. We matched 3 controls to each case on maternal age, year of giving birth and birth facility. Information on terminations (induced and spontaneous) before the birth of record, the matched factors and potential confounders were collected from the birth certificate. After adjustment for the matched factors, age, parity and maternal and paternal education, the odds ratio associating any termination history with breast cancer risk equaled 0.91 (95% CI = 0.79–1.05). The marginally protective adjusted odds ratio largely derived from a protective effect among women with parity equaled to 1 (OR for any termination = 0.68; 95% CI = 0.45–1.03), suggesting a protective effect of terminated pregnancy among women with one live birth. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. The 21‐gene recurrence score (RS) assay has been reported to accurately predict the risk of disease recurrence and chemotherapy benefit in women with estrogen receptor (ER)‐positive, lymph node (LN)‐negative breast cancer who are treated with tamoxifen. To the authors' k
## Abstract The authors report on the incidence rates of breast cancer overall and by histology in a population of unscreened women constituting ∼80% of the total population of women in Denmark from 1973–2002, utilizing the files of the nationwide Danish Cancer Registry. The age‐specific incidence
## Abstract To investigate the role of lifelong vegetarianism on the aetiology of female breast cancer, we conducted a population‐based case‐control study among South Asian migrant women from the Indian subcontinent resident in England. A total of 240 South Asian breast cancer cases were identified
## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e